Psoriatic arthritis

Cook MJ et al. Rheumatology (Oxford) 2018: key224. doi: 10.1093/rheumatology/key224

Merola JF, Herrera V, Palmer JB. Clin Rheumatol 2018. doi: 10.1007/s10067-018-4187-y

Mease PJ et al. J Rheumatol 2018. doi: 10.3899/jrheum.171094

Coiffier G et al. Clin Rheumatol 2018. doi: 10.1007/s10067-018-4160-9

Michelsen B et al. Ann Rheum Dis 2018. doi: 10.1136/annrheumdis-2018-213286

Husni M et al. Arthritis Res Ther 2018; 20: 102. doi: 10.1186/s13075-018-1601-4

Feld J et al. Nat Rev Rheumatol 2018; 14: 363–371. doi: 10.1038/s41584-018-0006-8

Bergman and Lunholm summarize the many disease-specific, treatment-specific, and psychosocial risks associated with psoriatic arthritis and provide guidance on mitigating these risks to improve quality of life.

Bergman M & Lundholm A. Arthritis Res Ther 2017;19:63. doi:10.1186/s13075-017-1265-5

Kavanaugh et al. examine the impact of psoriatic arthritis on daily activity and identify unmet needs for better screening, diagnosis, and education about treatment options and adherence.

Kavanaugh A, Helliwell P, & Ritchlin CT. Rheumatol Ther 2016;3:91–102. doi:10.1007/s40744-016-0029-z

In this chapter, the authors review the epidemiology of psoriasis and psoriatic arthritis throughout the world by examining the existing literature.

Perez-Alamino R et al. In: Psoriatic Arthritis and Psoriasis. Edited by Adebajo A et al. Springer International Publishing Switzerland, 2016. doi:10.1007/978-3-319-19530-8_4

This chapter provides a concise overview of psoriatic arthritis, discussing the epidemiology and classification, clinical features, differential diagnosis, and clinical assessment of the disease.

Koehm M, Behrens F. In: Psoriatic Arthritis and Psoriasis. Edited by Adebajo A et al. Springer International Publishing Switzerland, 2016. doi:10.1007/978-3-319-19530-8_17

Coates et al. discuss the etiology of psoriatic arthritis, including genetic and environmental factors. Various inflammatory pathways are also briefly discussed in this chapter.

In: Handbook of Psoriatic Arthritis and Psoriasis. Edited by Warren R, Menter A. Springer International Publishing Switzerland, 2016. doi:10.1007/978-3-319-18227-8_2

Ogdie and Gelfand review the basic epidemiologic principles of identifying risk factors before summarizing the evidence to date about risk factors for psoriatic arthritis among patients with psoriasis.

Ogdie A & Gelfand JM. Curr Rheumatol Rep 2015;17:64. doi:10.1007/s11926-015-0540-1

A review of the changes in the clinical picture and epidemiology of spondyloarthritis in light of the Assessment of SpondyloArthritis International Society (ASAS) classification criteria.

Nat Rev Rheumatol 2015;11:110–118. doi:10.1038/nrrheum.2014.181

Data reviewing the prevalence of spondyloarthritis in different populations, and indicating how the introduction of new classification criteria might have an impact on the epidemiology.

Bakland G & Nossent HC. Curr Rheumatol Rep 2013;15:351. doi:10.1007/s11926-013-0351-1